Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Anika Therapeutics (ANIK) Return on Assets (2016 - 2025)

Historic Return on Assets for Anika Therapeutics (ANIK) over the last 15 years, with Q3 2025 value amounting to 0.1%.

  • Anika Therapeutics' Return on Assets fell 500.0% to 0.1% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.1%, marking a year-over-year decrease of 500.0%. This contributed to the annual value of 0.2% for FY2024, which is 500.0% up from last year.
  • Anika Therapeutics' Return on Assets amounted to 0.1% in Q3 2025, which was down 500.0% from 0.25% recorded in Q2 2025.
  • Over the past 5 years, Anika Therapeutics' Return on Assets peaked at 0.04% during Q2 2024, and registered a low of 0.25% during Q2 2025.
  • Over the past 5 years, Anika Therapeutics' median Return on Assets value was 0.02% (recorded in 2022), while the average stood at 0.06%.
  • Its Return on Assets has fluctuated over the past 5 years, first soared by 800bps in 2021, then crashed by -2900bps in 2025.
  • Quarter analysis of 5 years shows Anika Therapeutics' Return on Assets stood at 0.02% in 2021, then plummeted by -98bps to 0.0% in 2022, then crashed by -2628bps to 0.01% in 2023, then plummeted by -1824bps to 0.22% in 2024, then skyrocketed by 55bps to 0.1% in 2025.
  • Its Return on Assets was 0.1% in Q3 2025, compared to 0.25% in Q2 2025 and 0.23% in Q1 2025.